Clinical Trial Update: Hydrocortisone for Term Hypotension [Phase 3]

View source ↗

Summary

Phase 3 trial of hydrocortisone for term neonatal hypotension has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension in Newborns
• Term Newborn Cardiovascular Insufficiency

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Diseases, Cardiovascular Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2019-04-02